Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sarvesh Chelvanambi, Ph.D.

Concepts (77)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sarvesh Chelvanambi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sarvesh Chelvanambi has written about over time.
nef Gene Products, Human Immunodeficiency Virus, 3 publications between 2015 and 2019, average publication date February 2018. Cell Death, 1 publications between 2019 and 2019, average publication date February 2019. Endothelium, 1 publications between 2019 and 2019, average publication date February 2019. Jurkat Cells, 1 publications between 2019 and 2019, average publication date February 2019. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2019 and 2019, average publication date August 2019. rac1 GTP-Binding Protein, 1 publications between 2019 and 2019, average publication date August 2019. HIV Infections, 5 publications between 2015 and 2023, average publication date October 2019. Hypertension, Pulmonary, 1 publications between 2020 and 2020, average publication date December 2019. NAD, 1 publications between 2020 and 2020, average publication date December 2019. Endothelial Cells, 3 publications between 2019 and 2021, average publication date February 2020. Toll-Like Receptor 4, 1 publications between 2020 and 2020, average publication date September 2020. PPAR alpha, 1 publications between 2021 and 2021, average publication date April 2021. Systems Analysis, 1 publications between 2021 and 2021, average publication date April 2021. Vascular Grafting, 1 publications between 2021 and 2021, average publication date April 2021. Vena Cava, Inferior, 1 publications between 2021 and 2021, average publication date April 2021. Macrophages, 3 publications between 2019 and 2023, average publication date May 2021. Endogenous Retroviruses, 1 publications between 2023 and 2023, average publication date April 2023.

To see the data from this visualization as text, click here.
Chelvanambi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (77)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.